Results 221 to 230 of about 88,362 (256)

FDA Approval Summary: Lisocabtagene Maraleucel for Relapsed or Refractory Follicular Lymphoma. [PDF]

Clin Cancer Res
Britton K, Mahat U, Richardson NC, Tegenge M, Gao Q, Theoret MR, Fashoyin-Aje LA.   +6 more
europepmc   +1 more source

Clinical Risk Stratification and Modifiable Risk Factors for Hepatitis B Virus-Related Follicular Lymphoma. [PDF]

Immunotargets Ther
Deng Y, Jia Z, Zhang H, Zhang X, Liu L, Wang X, Song H, Zhang Z, Liu C, Zhang Q, Ma J.   +10 more
europepmc   +1 more source

Response Duration During Treatment of Patients with Follicular Lymphoma. [PDF]

Biomedicines
Kiss E, Illés Á, Jóna Á.
europepmc   +1 more source

Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-Cell lymphoma [PDF]

, 2017
Bartlett, N. L, et al,, Ghobadi, A.
core   +1 more source

Combination of Metronomic Chemotherapy and Rituximab in Frail and Elderly Patients with Relapsed/Refractory Follicular Lymphoma and Ineligible for Lenalidomide Treatment: A Retrospective Analysis. [PDF]

Cancers (Basel)
Pelliccia S, Banchi M, De Marchi L, Cencini E, Seimonte C, Fabbri A, Nunzi A, Destefano S, Bocci G, Cox MC.   +9 more
europepmc   +1 more source

Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma.

Blood
Falchi L, Sureda A, Leppä S, Vermaat JSP, Nijland M, Christensen JH, de Vos S, Holte H, Merryman RW, Lugtenburg PJ, Abrisqueta P, Linton KM, Sunkersett G, Hoehn D, Rana A, Abbas A, Marek J, Hao Y, Steele AJ, Morehouse C, Hutchings M, Belada D.   +21 more
europepmc   +1 more source

CD19 Directed CAR T Therapy for Transformed Follicular Lymphoma: A CIBMTR Analysis. [PDF]

Am J Hematol
Thiruvengadam SK, Ahn KW, Patel J, Lian Q, Hertzberg M, Epperla N, Metheny L, Hong S, Jain T, Aljurf M, Beitinjaneh A, Vaughn J, Gopal A, Iqbal M, Wirk B, Manjappa S, Oliver C, Mohty R, Shadman M, Turtle C, Hamadani M, Herrera AF.   +21 more
europepmc   +1 more source

A SWOT-Consensus for CAR-T in Follicular Lymphoma: Fine Tuning of Patient Journey and Selection. [PDF]

Hematol Oncol
Marchetti M, Corradini P, Arcaini L, Bramanti S, Di Rocco A, Ladetto M, Luminari S, Rigacci L, Zinzani PL.   +8 more
europepmc   +1 more source

Follicular Lymphoma Manifesting as an Isolated Colorectal Polyp-Like Morphology. [PDF]

JGH Open
Hamada Y, Umeda Y, Nakagawa H.
europepmc   +1 more source

Clinical insights into duodenal-type follicular lymphoma: case series study. [PDF]

Clin Endosc
Choe AR, Jun YJ, Cho MS, Tae CH, Jung SA, Shim KN.   +5 more
europepmc   +1 more source